Using machine-learning training with the Cancer Genome Atlas (TCGA) RCC cohort, we developed unique gene signatures defining either a subset of proliferative CD8+ T cells or a subset of DC-like TAMs. The gene discussed is CD8A; the disease is renal cell carcinoma.